Literature DB >> 19489733

The role of ubiquitin in NF-kappaB regulatory pathways.

Brian Skaug1, Xiaomo Jiang, Zhijian J Chen.   

Abstract

Nuclear factor kappa enhancer binding protein (NF-kappaB) regulates diverse biological processes including immunity, inflammation, and apoptosis. A vast array of cellular stimuli converges on NF-kappaB, and ubiquitination plays an essential role in the coordination of these signals to regulate NF-kappaB activity. At least three steps in NF-kappaB activation directly involve ubiquitination: proteasomal degradation of inhibitor of NF-kappaB (IkappaB), processing of NF-kappaB precursors, and activation of the transforming growth factor (TGF)-beta-activated kinase (TAK1) and IkappaB kinase (IKK) complexes. In this review, we discuss recent advances in the identification and characterization of ubiquitination and deubiquitination machinery that regulate NF-kappaB. Particular emphasis is given to proteasome-independent functions of ubiquitin, specifically its role in the activation of protein kinase complexes and in coordination of cell survival and apoptosis signals downstream of tumor necrosis factor alpha (TNFalpha).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19489733     DOI: 10.1146/annurev.biochem.78.070907.102750

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  227 in total

1.  Ubiquitin chain trimming recycles the substrate binding sites of the 26 S proteasome and promotes degradation of lysine 48-linked polyubiquitin conjugates.

Authors:  Nan-Yan Zhang; Andrew D Jacobson; Andrea Macfadden; Chang-Wei Liu
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

2.  Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29.

Authors:  Hui Li; Emilia Solomon; Sara Duhachek Muggy; Danqiong Sun; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

3.  Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNFα-induced NF-κB activation via mediating TAK1 degradation.

Authors:  Yihui Fan; Yi Shi; Shangfeng Liu; Renfang Mao; Lei An; Yanling Zhao; Hong Zhang; Fuchun Zhang; Guotong Xu; Jun Qin; Jianhua Yang
Journal:  Cell Signal       Date:  2012-03-03       Impact factor: 4.315

4.  The E3 ubiquitin ligase MIB1 negatively regulates basal IκBα level and modulates NF-κB activation.

Authors:  Li-Juan Liu; Tian-Tian Liu; Yong Ran; Ying Li; Xiao-Dong Zhang; Hong-Bing Shu; Yan-Yi Wang
Journal:  Cell Res       Date:  2011-12-20       Impact factor: 25.617

5.  KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.

Authors:  Jianhua Ling; Ya'an Kang; Ruiying Zhao; Qianghua Xia; Dung-Fang Lee; Zhe Chang; Jin Li; Bailu Peng; Jason B Fleming; Huamin Wang; Jinsong Liu; Ihor R Lemischka; Mien-Chie Hung; Paul J Chiao
Journal:  Cancer Cell       Date:  2012-01-17       Impact factor: 31.743

6.  Ubiquitination: Added complexity in Ras and Rho family GTPase function.

Authors:  Michelle de la Vega; James F Burrows; James A Johnston
Journal:  Small GTPases       Date:  2011-07-01

Review 7.  Aging and immune function: molecular mechanisms to interventions.

Authors:  Subramaniam Ponnappan; Usha Ponnappan
Journal:  Antioxid Redox Signal       Date:  2011-01-08       Impact factor: 8.401

Review 8.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

Review 9.  Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease.

Authors:  Monte S Willis; W H Davin Townley-Tilson; Eunice Y Kang; Jonathon W Homeister; Cam Patterson
Journal:  Circ Res       Date:  2010-02-19       Impact factor: 17.367

10.  Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.

Authors:  M Sisto; A Barca; D D Lofrumento; S Lisi
Journal:  Clin Exp Immunol       Date:  2016-02-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.